Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-11-13

Clinical Trial Update: The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) Patients [NA]

View source ↗

Summary

Clinical trial update examining how serotonergic modulation affects intestinal permeability and visceral hypersensitivity in healthy volunteers and patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Irritable Bowel Syndrome | NA | Status: COMPLETED